We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

38 hedge funds and large institutions have $18M invested in Assembly Biosciences in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 10 increasing their positions, 18 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.49% less ownership

Funds ownership: 2.86% → 2.37% (-0.49%)

24% less funds holding

Funds holding: 50 → 38 (-12)

34% less capital invested

Capital invested by funds: $27.2M → $18M (-$9.19M)

44% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 18

92% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 12

Holders
38
Holders Change
-12
Holders Change %
-24%
% of All Funds
0.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
10
Reduced
18
Closed
12
Calls
$25K
Puts
–
Net Calls
+$25K
Net Calls Change
-$22K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$315K
2
Citadel Advisors
Citadel Advisors
Florida
+$116K
3
Jane Street
Jane Street
New York
+$93.7K
4
Franklin Resources
Franklin Resources
California
+$63.4K
5
TRCT
Tower Research Capital (TRC)
New York
+$48.5K

Top Sellers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
-$1.66M
2
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$935K
3
PIM
Platinum Investment Management
Australia
-$507K
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$416K
5
MAM
Marquette Asset Management
Minnesota
-$96K

ASMB Hedge Fund Activity: Q4 2022 in Review

38 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q4 2022, worth a combined $18M — down 34% from $27.2M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of ASMB and 1 opened new positions — a net loss of 11 holders — while 18 trimmed existing stakes and 10 added.

The largest buyer was Renaissance Technologies, adding an estimated $315K. The largest seller was Deep Track Capital, cutting an estimated $1.66M.

  • 38 institutional investors held Assembly Biosciences (ASMB) as of Q4 2022, down from 50 in Q3 2022.
  • Funds reported $18M of Assembly Biosciences stock for Q4 2022, down 34% quarter-over-quarter.
  • 1 fund opened new Assembly Biosciences positions in Q4 2022 and 12 closed out, a net change of -11 holders.
  • The largest Assembly Biosciences buyer in Q4 2022 was Renaissance Technologies, an estimated $315K added.
  • The largest Assembly Biosciences seller in Q4 2022 was Deep Track Capital, an estimated $1.66M sold.

Based on aggregated 13F filings for Q4 2022.